GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » EV-to-FCF

Binex Co (XKRX:053030) EV-to-FCF : -25.62 (As of Apr. 16, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Binex Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Binex Co's Enterprise Value is ₩532,368 Mil. Binex Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-20,778 Mil. Therefore, Binex Co's EV-to-FCF for today is -25.62.

The historical rank and industry rank for Binex Co's EV-to-FCF or its related term are showing as below:

XKRX:053030' s EV-to-FCF Range Over the Past 10 Years
Min: -50093.18   Med: 24.33   Max: 2543.84
Current: -25.37

During the past 13 years, the highest EV-to-FCF of Binex Co was 2543.84. The lowest was -50093.18. And the median was 24.33.

XKRX:053030's EV-to-FCF is ranked worse than
100% of 451 companies
in the Biotechnology industry
Industry Median: 2.21 vs XKRX:053030: -25.37

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-16), Binex Co's stock price is ₩15970.00. Binex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-1126.000. Therefore, Binex Co's PE Ratio (TTM) for today is At Loss.


Binex Co EV-to-FCF Historical Data

The historical data trend for Binex Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binex Co EV-to-FCF Chart

Binex Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.98 52.94 -19.38 -25.60 -29.15

Binex Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.60 -29.59 -14.13 -24.01 -29.15

Competitive Comparison of Binex Co's EV-to-FCF

For the Biotechnology subindustry, Binex Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binex Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Binex Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Binex Co's EV-to-FCF falls into.


;
;

Binex Co EV-to-FCF Calculation

Binex Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=532367.619/-20778.365
=-25.62

Binex Co's current Enterprise Value is ₩532,368 Mil.
Binex Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-20,778 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Binex Co  (XKRX:053030) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Binex Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15970.00/-1126.000
=At Loss

Binex Co's share price for today is ₩15970.00.
Binex Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1126.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Binex Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Binex Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Binex Co Business Description

Traded in Other Exchanges
N/A
Address
480-2 Janglim-dong, Saha-gu, Busan, KOR, 604-846
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.

Binex Co Headlines

No Headlines